{
  "id": 62010,
  "title": "#Aids2026: Bhekisisa analysed SA’s first LEN roll-out data. Here's what it found",
  "url": "https://urgent.news/2026/08/02/aids2026-bhekisisa-analysed-sas-first-len-roll-out-data-heres-what-it",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-02T22:12:48.000Z",
  "source": {
    "name": "Mail and Guardian",
    "slug": "mail-and-guardian",
    "url": "https://mg.co.za/news/health/2026-08-02-aids2026-bhekisisa-analysed-sa-s-first-len-roll-out-data-here-s-what-it-found/"
  },
  "original_language": "en",
  "account": null,
  "summary": "South Africa accounts for over half of all lenacapavir (LEN) users in Africa, with health department data revealing 31,297 of the continent's roughly 60,000 users are in the country. This article delves into the first six weeks of the LEN rollout, examining user demographics, its effect on overall HIV prevention uptake, and the country's dose supply.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}